Dusty Marie Narducci
Objective: Determine the number of athletes with electronic medical record (EMR) documentation of penicillin (PCN) allergy and enroll them into a PCN relabeling program using EMR risk stratification (EMR-RS) or team physician risk stratification (TP-RS) to determine the presence of true allergy.
Design: Retrospective data analysis, prospective cohort study.
Setting: Division 1 University Athletic Program.
Patients: Athletes with an EMR document PCN allergy (27 of 415).
Interventions: Athletes labeled as allergic to PCN were enrolled into a PCN relabeling program and appropriately categorized using EMR-RS and TP-RS. Athletes who were determined appropriate were offered recommendations for potential relabeling of their PCN allergy.
Outcome Measures: This QI study sought to establish the prevalence of true PCN allergy among athletes. Both EMRRS and TP-RS relabeling strategies were used to determine which method would more accurately identify true PCN allergy.
Results: From the 6.5% of athletes identified with as allergic to PCN, TP-RS was able to identify 92.59% of athletes to be falsely labeled as allergic to PCN, compared to 40.7% identified by EMR-RS a difference of 51.89%.
Conclusions: TP-RS is superior to EMR-RS for identifying falsely documented PCN allergies in athletes. TP-RS should be used to re-label athletes to decrease the use of unnecessary antibiotics, decrease healthcare costs, limit adverse events associated with antibiotic use, and prevent antimicrobial resistance in the athletic population.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu